Investigating novel thiazolyl-indazole derivatives as scaffolds for SARS-CoV-2 MPro inhibitors

Docking (animal) Linker
DOI: 10.1016/j.ejmcr.2022.100034 Publication Date: 2022-02-10T03:01:22Z
ABSTRACT
COVID-19 is a global pandemic caused by infection with the SARS-CoV-2 virus. Remdesivir, RNA polymerase inhibitor, only drug to have received widespread approval for treatment of COVID-19. The main protease enzyme (M
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (87)
CITATIONS (2)